Nonalcoholic fatty liver in a developing country is responsible for significant liver disease
- PMID: 20725907
- DOI: 10.1002/hep.23838
Nonalcoholic fatty liver in a developing country is responsible for significant liver disease
Comment on
-
Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease.Hepatology. 2010 May;51(5):1593-602. doi: 10.1002/hep.23567. Hepatology. 2010. PMID: 20222092
Similar articles
-
The epidemiology of nonalcoholic fatty liver disease in adults.J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S5-10. doi: 10.1097/01.mcg.0000168638.84840.ff. J Clin Gastroenterol. 2006. PMID: 16540768 Review.
-
Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious.Hepatology. 2006 Oct;44(4):802-5. doi: 10.1002/hep.21391. Hepatology. 2006. PMID: 17006914 No abstract available.
-
Hepatocellular carcinoma and NASH.J Gastroenterol. 2004;39(4):409-11. doi: 10.1007/s00535-004-1332-y. J Gastroenterol. 2004. PMID: 15168260 No abstract available.
-
NASH and HCC.Clin Liver Dis. 2009 Nov;13(4):631-47. doi: 10.1016/j.cld.2009.07.007. Clin Liver Dis. 2009. PMID: 19818310
-
[Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].Ned Tijdschr Geneeskd. 2005 Feb 5;149(6):289-94. Ned Tijdschr Geneeskd. 2005. PMID: 15730035 Review. Dutch.
Cited by
-
Prevalence of Risk Factors for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Patients With Cryptogenic Cirrhosis.J Clin Exp Hepatol. 2022 Mar-Apr;12(2):492-502. doi: 10.1016/j.jceh.2021.05.008. Epub 2021 Jun 16. J Clin Exp Hepatol. 2022. PMID: 35535099 Free PMC article.
-
Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study.Turk J Gastroenterol. 2021 Dec;32(12):1019-1028. doi: 10.5152/tjg.2021.201171. Turk J Gastroenterol. 2021. PMID: 34876392 Free PMC article.
-
High prevalence of non-alcoholic fatty liver disease among healthy male blood donors of urban India.JGH Open. 2019 Jan 16;3(2):133-139. doi: 10.1002/jgh3.12117. eCollection 2019 Apr. JGH Open. 2019. PMID: 31061888 Free PMC article.
-
Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial.JGH Open. 2017 Oct 12;1(2):62-67. doi: 10.1002/jgh3.12010. eCollection 2017 Oct. JGH Open. 2017. PMID: 30483536 Free PMC article.
-
A Prospective Randomised Comparative Four-arm Intervention Study of Efficacy and Safety of Saroglitazar and Vitamin E in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH)-SVIN TRIAL.J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101398. doi: 10.1016/j.jceh.2024.101398. Epub 2024 Mar 18. J Clin Exp Hepatol. 2024. PMID: 38628977
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical